David P. Kerstein
2021
In 2021, David P. Kerstein earned a total compensation of $1.1M as Chief Medical Officer at Theseus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $163,330 |
|---|---|
| Option Awards | $486,084 |
| Salary | $409,667 |
| Total | $1,059,081 |
Kerstein received $486.1K in option awards, accounting for 46% of the total pay in 2021.
Kerstein also received $163.3K in non-equity incentive plan and $409.7K in salary.
Rankings
In 2021, David P. Kerstein's compensation ranked 8,604th out of 12,406 executives tracked by ExecPay. In other words, Kerstein earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,604 out of 12,406 | 31st |
Division Manufacturing | 3,811 out of 5,492 | 31st |
Major group Chemicals And Allied Products | 1,686 out of 2,368 | 29th |
Industry group Drugs | 1,500 out of 2,089 | 28th |
Industry Pharmaceutical Preparations | 1,117 out of 1,536 | 27th |
Source: SEC filing on April 26, 2023.
Kerstein's colleagues
We found four more compensation records of executives who worked with David P. Kerstein at Theseus Pharmaceuticals in 2021.